Routine

Mild cognitive impairment

Cognitive decline without dementia · Neurology
Physician-written · Verified by three sets of doctors · Reviewed November 2026

Bedside summary

Objective cognitive impairment greater than expected for age but without significant loss of independence, representing a transitional state with elevated risk of progression to dementia. Evaluation focuses on excluding reversible causes and identifying the underlying aetiology.

Red flags

  • Rapid progression (consider prion, autoimmune or structural cause)
  • Functional decline indicating dementia
  • Focal neurological signs
  • Features of depression with suicidality
  • Reversible cause overlooked

Assessment

Differential diagnosis

  • Normal cognitive ageing
  • Early Alzheimer's or other dementia
  • Depression (pseudodementia)
  • Medication effects or polypharmacy
  • Thyroid disease, B12 deficiency or other reversible cause
  • Obstructive sleep apnoea

Investigations

  • Formal cognitive testing (MoCA) and collateral history
  • Bloods: TFT, B12, folate, calcium, glucose, renal/liver function
  • Depression screen
  • Medication review for cognitive effects
  • MRI brain for pattern of atrophy/vascular disease
  • Consider CSF/amyloid biomarkers or specialist tests where aetiology relevant to management

Management

  • Confirm objective impairment with preserved functional independence
  • Obtain collateral history on progression and daily function
  • Screen for and treat reversible contributors (depression, drugs, thyroid, B12, sleep apnoea)
  • Characterise the cognitive profile (amnestic vs non-amnestic)
  • Image to assess for vascular or degenerative changes
  • Discuss prognosis and the variable risk of progression honestly
  • Optimise vascular risk factors and promote exercise and cognitive engagement
  • Avoid routine use of cholinesterase inhibitors (not indicated in MCI)
  • Arrange cognitive follow-up to detect progression
  • Provide advice on driving, finances and advance planning as appropriate

Drugs & doses

No drug is approved to treat MCI itself; treat reversible causes
Cholinesterase inhibitors are not recommended in MCI
Optimise vascular risk medication (antihypertensives, statins)
Treat depression (e.g. sertraline 50 mg PO daily) if present

Disposition

Primary care or memory clinic follow-up. Specialist referral for atypical, rapidly progressive or young-onset cases.

Complications & pitfalls

  • Progression to dementia
  • Missed reversible cause
  • Driving and safety risks
  • Anxiety about diagnosis
  • Inappropriate drug treatment

Exam pearls

  • MCI is a risk state, not a dementia diagnosis; many remain stable or improve
  • Always exclude depression, drugs, thyroid and B12 before attributing to neurodegeneration
  • Cholinesterase inhibitors have no role in MCI
  • Amnestic MCI carries the highest risk of progression to Alzheimer's disease

Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.